Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) EPS (Basic): 2009-2021

Historic EPS (Basic) for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Dec 2021 value amounting to -$1.46.

  • Avadel Pharmaceuticals' EPS (Basic) fell 71.60% to -$0.39 in Q4 2021 from the same period last year, while for Dec 2021 it was -$1.51, marking a year-over-year decrease of 153.78%. This contributed to the annual value of -$1.46 for FY2021, which is 1222.56% down from last year.
  • Latest data reveals that Avadel Pharmaceuticals reported EPS (Basic) of -$1.46 as of FY2021, which was down 1,222.56% from $0.13 recorded in FY2020.
  • Over the past 5 years, Avadel Pharmaceuticals' EPS (Basic) peaked at $1.69 during FY2017, and registered a low of -$2.55 during FY2018.
  • Its 3-year average for EPS (Basic) is -$0.74, with a median of -$0.89 in 2019.
  • In the last 5 years, Avadel Pharmaceuticals' EPS (Basic) surged by 269.00% in 2017 and then plummeted by 1,222.56% in 2021.
  • Over the past 5 years, Avadel Pharmaceuticals' EPS (Basic) (Yearly) stood at $1.69 in 2017, then slumped by 250.89% to -$2.55 in 2018, then soared by 65.10% to -$0.89 in 2019, then soared by 114.61% to $0.13 in 2020, then tumbled by 1,222.56% to -$1.46 in 2021.